Identification of Multiple Genetic Susceptibility Loci in Takayasu Arteritis  by Saruhan-Direskeneli, Güher et al.
REPORT
Identification of Multiple Genetic
Susceptibility Loci in Takayasu Arteritis
Gu¨her Saruhan-Direskeneli,1 Travis Hughes,2 Kenan Aksu,3 Gokhan Keser,3 Patrick Coit,2
Sibel Z. Aydin,4,5 Fatma Alibaz-Oner,4 Sevil Kamalı,6 Murat Inanc,6 Simon Carette,7 Gary S. Hoffman,8
Servet Akar,9 Fatos Onen,9 Nurullah Akkoc,9 Nader A. Khalidi,10 Curry Koening,11 Omer Karadag,12
Sedat Kiraz,12 Carol A. Langford,8 Carol A. McAlear,13 Zeynep Ozbalkan,14 Askin Ates,14,15
Yasar Karaaslan,14,16 Kathleen Maksimowicz-McKinnon,17,18 Paul A. Monach,19 Hu¨seyin T. Ozer,20
Emire Seyahi,21 Izzet Fresko,21 Ayse Cefle,22 Philip Seo,23 Kenneth J. Warrington,24
Mehmet A. Ozturk,25 Steven R. Ytterberg,24 Veli Cobankara,26 A. Mesut Onat,27 Joel M. Guthridge,28
Judith A. James,28 Ercan Tunc,29 Nursxen Duzgun,15 Muge Bıcakcıgil,30 Sibel P. Yentu¨r,1
Peter A. Merkel,13 Haner Direskeneli,4 and Amr H. Sawalha2,*
Takayasu arteritis is a rare inflammatory disease of large arteries. The etiology of Takayasu arteritis remains poorly understood, but
genetic contribution to the disease pathogenesis is supported by the genetic associationwithHLA-B*52. We genotyped ~200,000 genetic
variants in two ethnically divergent Takayasu arteritis cohorts from Turkey and North America by using a custom-designed genotyping
platform (Immunochip). Additional genetic variants and the classical HLA alleles were imputed and analyzed. We identified and
confirmed two independent susceptibility loci within the HLA region (r2 < 0.2): HLA-B/MICA (rs12524487, OR ¼ 3.29, p ¼ 5.57 3
1016) and HLA-DQB1/HLA-DRB1 (rs113452171, OR ¼ 2.34, p ¼ 3.74 3 109; and rs189754752, OR ¼ 2.47, p ¼ 4.22 3 109). In addi-
tion, we identified and confirmed a genetic association between Takayasu arteritis and the FCGR2A/FCGR3A locus on chromosome
1 (rs10919543, OR ¼ 1.81, p ¼ 5.89 3 1012). The risk allele in this locus results in increased mRNA expression of FCGR2A. We also
established the genetic association between IL12B and Takayasu arteritis (rs56167332, OR ¼ 1.54, p ¼ 2.18 3 108).Takayasu arteritis (MIM 207600) is a rare large-vessel vascu-
litis characterized by nonspecific inflammation of the aorta
and its major branches.1 This inflammatory process leads
to blood vessel wall thickening, fibrosis, progressive occlu-
sion, and dilatation, resulting in limb- and organ-threat-
ening ischemia and the characteristic absence of pulses
in the extremities. Other nonspecific symptoms may
include weight loss, fever, night sweats, fatigue, arthralgia,
and myalgia.2 The disease typically presents in the second
or third decade, but approximately 20% of cases occur
before the age of 20 and 20% after the age of 40.3 The dis-
ease is most prevalent in Far East Asia, India, and Mexico,
and tends to be less common in European-derived popula-
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common in women; however, the female-to-male ratio is
dependent upon ethnicity and geographical location.2,5
The etiology and pathogenesis of Takayasu arteritis is
largely unknown. The evidence for a genetic contribution
to Takayasu arteritis comes from ethnic differences in the
prevalence of the disease, familial aggregation, and the
confirmed genetic association within the HLA region.5
The association withHLA-B*52 is themost significant asso-
ciation in the HLA region in Japanese, but other HLA
alleles (including HLA-B*39, HLA-DRB1*1502, and HLA-
DRB1*0405) have also been associated with the disease
in Japanese.1 The association with HLA-B*52 has been
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Figure 1. Manhattan Plot Showing the Results of a Meta-analysis between the Two Cohorts of Cases with Takayasu Arteritis and
Controls Included in This Study
The log10 p values for each genetic variant evaluated are plotted against its chromosomal location.Turkey.9 Interestingly, individuals with Takayasu arteritis
with HLA-B*52 tend to have more severe disease with a
higher incidence of left ventricular wall abnormalities
and aortic regurgitation and an earlier disease onset.9,10
In contrast, the presence of HLA-B*39 allele is associated
with the development of renal artery stenosis in Takayasu
arteritis.11 Genetic associations with polymorphisms
within cytokine genes such as IL2 (MIM 147680), IL6
(MIM 147620), and IL12B (MIM 161561) have been
recently reported in Turkish cases.12
We studied two independent cohorts of Takayasu arter-
itis cases and controls from Turkey and North America.
The Turkish cohort consisted of 339 cases and 516 healthy
controls, and the North American cohort consisted of 112
European-American (EA) cases enrolled in the Vasculitis
Clinical Research Consortium Longitudinal Study of
Takayasu Arteritis and 599 EA controls. All cases fulfilled
the 1990 American College of Rheumatology classification
criteria for Takayasu arteritis.13 Our study was approved by
the Institutional Review Boards and the Ethics Committees
at our institutions, and all study participants signed an
informed written consent.
Genotyping was performed with the Human Immuno
DNAAnalysis BeadChipKit (Immunochip),which includes
196,524 genetic variants primarily in genetic susceptibility
loci previously shown to confer risk for autoimmune or
inflammatory diseases. Rigorous quality-control measures
were applied and samples were removed from the analysis
basedonpopulation stratificationbyprincipal components
analysis (>4 standard deviations), identity by descentThe Amer(IBD > 0.4), and autosomal heterozygosity (>2 standard
deviation around the mean). Principal components
analysis was performed with Eigenstrat.14 IBD and
heterozygosity analysis were performed with PLINK.15
Genotypedmarkers were filtered forminor allele frequency
(MAF > 0.01), genotype success rate (GSR > 0.9), and
Hardy-Weinberg equilibrium p value (HWPControls > 0.01,
HWPCases > 0.0001). In addition, markers with differential
missingness between cases and controls (p < 0.05) were
also excluded from the analysis. After applying the afore-
mentioned quality-control measures, a total of 124,393
variants in the Turkish cohort and 124,312 in the EA cohort
were evaluated. A total of 305 Turkish cases and 483 con-
trols and 106 EA cases and 553 controls were included in
the final analysis. A set of 3,120 variants that are not associ-
ated with autoimmunity and also included on the Immu-
nochip were filtered for MAF, GSR, HWP, and differential
missingness as above, and then used as ‘‘null’’ variants to
calculate genomic control lambda (lGC) in our cohorts.
We detected no to minimal residual population stratifica-
tion in our cohorts (lGC in the Turkish cohort ¼ 1.00 and
in the EA cohort ¼ 1.06). Meta-analysis was performed
with PLINK and haplotype analysis was performed with
Haploview v.4.2.16 Adjusted associations between SNPs
were performed with logistic regression in PLINK.
The 1000 Genomes Project data were used to impute
additional genetic variants in the associated loci that
we discovered, from a combined reference panel consis-
ting of 1,092 individuals.17 PLINK-formatted files were
converted to the appropriate format with GTOOL andican Journal of Human Genetics 93, 298–305, August 8, 2013 299
Figure 2. Results of the Meta-analysis Showing Genotyped and
Imputed Variants in the HLA Region
Two independent genetic effects are detected (r2 < 0.2).
(A) The entire HLA region evaluated in this study.
(B and C) Regional plots for themeta-analysis results in theHLA-B/
MICA locus (B) and the HLA-DQB1/HLA-DRB1 locus (C).
300 The American Journal of Human Genetics 93, 298–305, August 8imputation was performed with Impute 2.18 A stringent
posterior probability imputation threshold of 0.9 was
applied. Variants with MAF > 1%, imputation success
rate > 90%, and HWP > 0.0001 in controls were included
in the analysis.
Imputation of classical HLA alleles was performed with
9,156 genotyped variants in the HLA region. These vari-
ants were first cleaned, aligned, and phased with the
HLA*IMP software package according to established qual-
ity-control measures.19 Phased haplotypes consisting of
5,776 variants were used to impute the classical HLA alleles
in HLA-A (MIM 142800), HLA-B (MIM 142830), HLA-C
(MIM 142840), HLA-DQA1 (MIM 146880), HLA-DQB1
(MIM 604305), and HLA-DRB1 (MIM 142857). An imputa-
tion posterior probability of 0.9 was applied to assign allele
calls to phased and imputed haplotypes. Genetic associa-
tion analysis for imputed HLA alleles was performed in
PLINK with only samples in which both alleles were suc-
cessfully imputed in each locus. Adjusted associations
between SNPs and classical HLA alleles were calculated
with logistic regression in PLINK.
We detected evidence for genetic association in two loci
with a genome-wide level of significance (p < 5 3 108) in
Takayasu arteritis (Figure 1). The most significant genetic
association detected was in the HLA region (rs12524487;
pmeta ¼ 5.57 3 1016, pTurkish ¼ 4.42 3 107, pEA ¼
4.05 3 1012). We also detected a genetic association in
the region that includes the genes encoding Fc-gamma
receptor IIA (FCGR2A [MIM 146790]) and Fc-gamma recep-
tor IIIA (FCGR3A [MIM 146740]). Two additional associa-
tion effects that confer risk for Takayasu arteritis but did
not pass the threshold for genome-wide significance were
detected on chromosome 21 downstream of the gene
encoding proteasome (prosome, macropain) assembly
chaperone 1 (PSMG1 [MIM 605296]) and on chromosome
5 in the gene encoding for the P40 subunit of the inter-
leukin-12 (IL-12) and IL-23 (IL12B) (Figure 1).
To further fine-map and localize the genetic association
detected in the HLA region, we first imputed additional
genetic variants up to the density of the 1000 Genomes
Project in the region extending from chr6: 28,889,000 to
chr6: 33,000,000 (UCSC Genome Browser build hg19) as
previously described.20 A meta-analysis of genotyped or
imputed variants in the HLA extended region in both co-
horts was performed (Figure 2). Two independent genetic
associations were detected in the HLA class I and HLA class
II regions (r2< 0.2; Table S1 available online). Themost sig-
nificant association was with a variant in the HLA-B/MICA
locus between HLA-B and MICA (rs12524487, p ¼ 5.57 3
1016). An additional effect was observed in the HLA-
DQB1/HLA-DRB1 locus (rs113452171, p ¼ 3.74 3 109,
and rs189754752, p ¼ 4.22 3 109) (Table 1, Figures 2,
S1, and S2). Conditional logistic regression confirmedThe red line represents the genome-wide level of significance
(p ¼ 5 3 108). Genotyped and imputed variants are shown in
diamonds and circles, respectively.
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Table 1. Genetic Association Results Showing theMost Significant Variant in Each of the Two Independent Genetic Effects Observed in the
HLA Region in Cases with Takayasu Arteritis
SNP (Minor
Allele)
Turkish European-American Meta-analysis
MAFCase MAFControl OR 95% CI p MAFCase MAFControl OR 95% CI p OR p Q Statistic p
HLA-B/MICA
rs12524487 (T) 0.105 0.04 2.79 (1.85–4.21) 4.42 3
107
0.217 0.067 3.85 (2.57–5.76) 4.05 3
1012
3.29 5.57 3
1016
0.27
HLA-DQB1/HLA-DRB1
rs113452171 (T) 0.185 0.093 2.21 (1.64–2.99) 1.42 3
107
0.048 0.015 3.43 (1.53–7.66) 0.0015 2.34 3.74 3
109
0.32
rs189754752 (G) 0.163 0.0795 2.26 (1.63–3.13) 5.46 3
107
0.0529 0.013 4.24 (1.90–9.47) 0.00014 2.47 4.22 3
109
0.16
Abbreviations are as follows: MAF, minor allele frequency; OR, odds ratio; CI, confidence interval.that these two effects in the HLA class I and HLA class II
regions are independent genetic susceptibility loci for
Takayasu arteritis (Table S2). The most significant variants
in the HLA-DQB1/HLA-DRB1 locus, however, are in tight
linkage disequilibrium (r2 ¼ 0.907 and 1, in the Turkish
and EA cohorts, respectively). Therefore, the genetic sus-
ceptibility locus in HLA class II probably represents one
genetic effect and could not be further localized to an indi-
vidual genetic variant.
To localize the genetic effect tagged by the variant
rs12524487 in the HLA-B/MICA locus, we identified all
genotyped and imputed variants that are in LD (r2 > 0.7)
with rs12524487 in the two cohorts included in this study
(Tables S3 and S4). In the EA cohort, the genetic effect in
rs12524487 remained significant when adjusted for the
effect in any of these additional variants, with the excep-
tion of variants with very strong LD (R0.9) in which
case conditional analysis was less informative. However,
in the Turkish cohort, there were only five additional
genetic variants in LD (r2 > 0.7) with rs12524487. Condi-
tional analysis suggests that the effect in two of these var-
iants is dependent on rs12524487, although very high LD
(r2 R 0.99) in the other three variants made conditional
analysis impossible. Taken together, transancestral map-
ping and conditional regression analysis fine maps the
effect tagged by rs12524487 in the HLA class I region to
four genetic variants (rs12524487, chr6: 31,359,160:D,
chr6: 31,359,428:D, and rs141706050). All these variants
are located in the intergenic region between HLA-B and
MICA (Tables S3 and S4).
Next, we used the genotyped variants in the HLA region
to impute the HLA classical alleles in both cohorts and per-
formed genetic association analysis to determine the asso-
ciation between classical HLA alleles and Takayasu arteritis.
We detected genetic association with two classical alleles
with a genome-wide level of significance (HLA-B*5201,
p ¼ 8.98 3 1010, and HLA-Cw*1202, p ¼ 4.01 3 1010)
(Table S5). HLA-B*5201 and HLA-Cw*1202 are in high
linkage disequilibrium (r2¼ 0.827 and 0.873 in the Turkish
and the EA cohorts, respectively) and therefore probably
represent the same genetic effect. The imputed allele fre-The Amerquency of HLA-B*5201 in normal Turkish controls in our
study (3.4%) is very similar to the reported genotyped
allele frequency of HLA-B*52 in Turkey (3.5%).21
We performed conditional regression analysis to deter-
mine the relationship between the genetic effect in the
HLA-B/MICA locus tagged by rs12524487 and the classical
HLA alleles HLA-B*5201/HLA-Cw*1202 (Table S6). In the
EA cohort, the effect in HLA-B*5201 and HLA-Cw*1202
remained significant after adjusting for rs12524487 and
the effect in rs12524487 remained significant after adjust-
ing for HLA-B*5201 and HLA-Cw*1202. On the other
hand, both effects are significantly attenuated when
adjusted for one another in the Turkish cohort (Table S6).
These findings are also supported by a relatively high LD
between rs12524487 and the HLA-B*5201 in the Turkish
cohort (r2 ¼ 0.674) and low LD between them in the
EA cohort (r2 ¼ 0.154). These data suggest that both
rs12524487 and the HLA classical alleles in the HLA
class I region contribute to the genetic effect in this locus.
Other suggestive associations (p < 5 3 105) between
classical HLA alleles and Takayasu arteritis in the meta-
analysis included HLA-B*1302 and HLA-Cw*0701. The
suggested genetic association with HLA-B*1302 confers
risk for Takayasu arteritis, whereas HLA-Cw*0701 seems
to exert a protective effect against the disease in both the
Turkish and the EA cohorts. These effects, however, do
not pass the threshold for genome-wide significance and
will require independent confirmation.
To fine map and localize the genetic association between
Takayasu arteritis and FCGR2A/FCGR3A, we imputed
additional genetic variants in this locus up to the 1000
Genomes Project density. The most significant association
in this locus was detected with the SNP rs10919543
(pmeta ¼ 5.89 3 1012, pTurkish ¼ 1.49 3 108, pEA ¼
6.71 3 105) (Figure 3). We identified two and three addi-
tional associated genetic variants that are in LD (r2 > 0.7)
with the index SNP rs10919543 in this locus in the Turkish
and the EA cohorts, respectively (Table 2). Very high link-
age disequilibrium precluded conditional analysis among
these variants and therefore this genetic effect could not
be further localized to a single variant. The index SNPican Journal of Human Genetics 93, 298–305, August 8, 2013 301
Figure 3. Genetic Association Results in the FCGR2A/FCGR3A
Region in Takayasu Arteritis
(A) Association results from the meta-analysis.
(B and C) Association results in the Turkish (B) and the European-
American (C) cohorts.
The red line represents the genome-wide level of significance
(p ¼ 5 3 108). Genotyped and imputed variants are shown in
302 The American Journal of Human Genetics 93, 298–305, August 8rs10919543 is not included in available expression quanti-
tative trait loci data sets. However, rs2099684, which is in
high linkage disequilibrium with rs10919543 (r2 ¼ 0.977
and 0.98 in the Turkish and EA cohorts, respectively)
(Table 2), is included in the GENe Expression VARiation
(Genevar) expression quantitative trait loci database.22
The disease-risk variant in rs2099684 (allele G) is associ-
ated with increased mRNA expression of FCGR2A in lym-
phoblastoid cells (p ¼ 3 3 104) (Figure S3).
The effect detected on chromosome 21q22 did not pass
the threshold for genome-wide significance and is primar-
ily derived from the EA cohort. Themost significantly asso-
ciated variant in this locus (p ¼ 4.393 107) is an imputed
indel (chr21: 40,462,378:D) located downstream of PSMG1
(Figure S4). Genetic association results in all genotyped or
imputed markers in this locus that are in linkage disequi-
librium (r2 > 0.7) with the index indel variant are pre-
sented in Table S7.
The most significant variant associated with Takayasu
arteritis on chromosome 5 in our study is rs56167332
(p ¼ 1.88 3 106), located ~70 kb upstream of IL12B
(Figure S5). This effect is primarily detected in the Turkish
cohort, and six additional variants in LD (r2 > 0.7) with
rs56167332 also show evidence for suggestive association
(Table S8). Conditional analysis suggests that rs56167332
or rs6871626 (r2 ¼ 0.98) explain the genetic effect in this
locus. The genetic association in all the other variants
in LD (r2 > 0.7) with rs56167332 became nonsignificant
upon conditioning on rs56167332 (Table S8). There were
30 variants in LD (r2 > 0.7) with rs56167332 in the EA
cohort, but only three variants (including rs56167332)
showed evidence for a suggestive association (p < 0.05).
Meta-analysis results for these three variants in both
cohorts are presented in Table S9. To further determine
whether the genetic association between IL12B and
Takayasu arteritis can be established with a genome-wide
level of significance, we imputed the variant rs56167332
into an additional set of 1,278 healthy controls
from Turkey (dbGaP Study Accession: phs000272.v1.p1).
Genetic association analysis between rs56167332 and
Takayasu arteritis in our Turkish cohort combined with
the additional Turkish controls was performed (OR ¼
1.60, 95% CI ¼ 1.34–1.91, p ¼ 1.34 3 107). A meta-
analysis with the EA cohort established this genetic associ-
ation in IL12B with a genome-wide level of significance
(p ¼ 2.18 3 108, OR ¼ 1.54, Q statistic p ¼ 0.40).
Our data reveal multiple genetic susceptibility loci for
Takayasu arteritis, a rare and poorly understood inflamma-
tory disease of the large arteries. This extensive genotyping
effort in Takayasu arteritis provides evidence for at least
two independent genetic susceptibility loci in the HLA
class I and class II regions and identifies and establishes a
genetic association in the FCGR2A/FCGR3A and IL12Bdiamonds and circles, respectively. The colors represent r2 values
with the index SNP in each locus (white, r2 < 0.2; yellow, r2 R
0.2–0.5; orange, r2 R 0.5–0.8; red, r2 R 0.8).
, 2013
Table 2. Genetic Association Results of theMost Significant SNP, rs10919543, in the FCGR2A/FCGR3A Locus andAll Genetic Variants in High
LD with This SNP
SNP (Minor
Allele)
Turkish European-American Meta-analysis
MAFCase MAFControl OR 95% CI p MAFCase MAFControl OR 95% CI p OR pmeta Q Statistic p
rs10919543 (G) 0.559 0.413 1.80 (1.47–2.22) 1.49 3
108
0.462 0.320 1.82 (1.35–2.46) 6.71 3 105 1.81 5.89 3
1012
0.952
rs10919544 (C) 0.560 0.413 1.81 (1.47–2.22) 1.50 3
108
0.458 0.325 1.75 (1.30–2.36) 0.0002012 1.79 1.61 3
1011
0.874
rs2099684 (G) 0.554 0.415 1.75 (1.43–2.15) 7.17 3
108
0.458 0.323 1.77 (1.32–2.39) 0.0001497 1.76 5.70 3
1011
0.951
rs141730227 (T) NA NA NA NA NA 0.462 0.324 1.79 (1.33–2.42) 0.000131 NA NA NA
NA: The SNP rs141730227 was not evaluated in the Turkish cohort because the genotype success rate (GSR) of 0.898 was below our GSR threshold for SNP
inclusion. However, when analyzed, it did show evidence for association (OR ¼ 1.735 [1.397–2.155], p ¼ 5.754 3 107).loci. Further analysis with imputed HLA classical alleles
validates and confirms the genetic association with HLA-
B*5201/HLA-Cw*1202 with a genome-wide level of signif-
icance. The genetic association within the HLA class I
region remains the most robust genetic susceptibility locus
for Takayasu arteritis.
Genetic associations between FCGR2A/FCGR3A and
other autoimmune and inflammatory diseases have
been well described. For example, the genetic association
between this locus and giant cell arteritis has been previ-
ously reported in a small cohort from Spain.23 This suggests
that these two large-vessel vasculitides can share common
genetic susceptibility loci. Indeed, there are notable similar-
ities between Takayasu arteritis and giant cell arteritis in
some clinical manifestations, angiographic findings, and
histopathological features of arterial lesions.24,25
The association between the FCGR2A/FCGR3A locus
and ulcerative colitis is robust and replicated.26,27 Interest-
ingly, retrospective analysis suggests that individuals with
Takayasu arteritis might have a higher prevalence of
other inflammatory and autoimmune diseases including
inflammatory bowel disease.28,29 The genetic susceptibility
conferred by variants in FCGR2A/FCGR3A could influence
the susceptibility to Takayasu arteritis through altering
the immune response against infectious agents that might
be involved in the pathogenesis of this disease. Indeed, we
show that the risk variant in this locus alters FCGR2A
expression. Previous reports suggest enhanced humoral
immune response to Mycobacterium tuberculosis antigens,
particularly the 65 kD heat shock protein, in Takayasu
arteritis compared to controls.30 More recently, genetic
sequences of Mycobacterium tuberculosis were detected in
aortic tissue from themajority of individuals with Takayasu
arteritis, supporting a role forMycobacterium tuberculosis in
the pathogenesis of this disease.31
A genetic association between IL12B and Takayasu arter-
itis has been previously suggested in a subset of our Turkish
cohort consisting of 94 cases and 108 controls.12 Our data
established the genetic association in this locus with a
genome-wide level of significance.
The genetic effect we detected in chromosome 21q22
requires further validation, because it did not pass theThe Amerthreshold for genome-wide significance in our study. It
should be noted that this same locus is also associated
with increased susceptibility to ulcerative colitis32 and
ankylosing spondylitis,33 two other inflammatory diseases.
In summary, our data indicate that genetic predisposi-
tion contributes to the susceptibility for Takayasu arteritis.
Genetic susceptibility loci in HLA and non-HLA loci have
been revealed with a genome-wide level of significance.
Indeed, the putative functional disease-associated variant
we identified in FCGR2A/FCGR3A increases FCGR2A
expression and might provide a mechanistic link between
a suspected role for infectious triggers and genetic predis-
position in Takayasu arteritis. The genetic association we
established in the IL12B locus (which encodes for the
common P40 subunit of IL-12 and IL-23) might have
therapeutic implications in Takayasu arteritis. Future
studies to further explore the functional consequences of
the disease-associated variants upon disease susceptibility
and to explore additional genetic susceptibility loci in
Takayasu arteritis and other large-vessel vasculitides are
warranted.Supplemental Data
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